Johnson & Johnson today announced that the company has submitted the OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration (FDA) in an application for De Novo classification.

Demand for robotic surgery is growing faster than the number of surgical robots being sold.

Who's Line Is It Anyway?'s long-running performer—was diagnosed with a detached retina, prompting him to seek emergency eye ...

St. Joseph’s/Candler is providing a valuable service, offering free hernia screenings to the community at two locations on ...